The USC Mark and Mary Stevens Neuroimaging and Informatics Institute (USC Stevens INI) is one of three institutions partnering in a five-year, $31.7 million grant from the National Institutes of Health (NIH) to merge many types of Alzheimer’s disease data in an effort to stimulate new drug development. This collective endeavor, known as the Alzheimer’s Disease Sequencing Project Phenotype Harmonization Consortium (ADSP-PHC), is a partnership between the USC Stevens INI, part of the Keck School of Medicine of USC, the Vanderbilt University Medical Center and the University of Miami.

To continue reading this story, click here.